There might be interest from big players end of this year which even TK haven't been in contact with (hence why he is still holding those 10M shares), 3 products with chronic respiratory screening very close to Class I regulatory approval which will place the final product in commercialisation stage and all of them have massive market....exciting time for the remainder of this year.
